Sierk Pötting

Chief Financial Officer & Chief Operating Officer at BioNTech SE

Sierk Pötting

Sierk Pötting

Chief Financial Officer & Chief Operating Officer at BioNTech SE

Overview
Career Highlights

BioNTech SE
Sandoz, Inc.

RelSci Relationships

1345

Birthday

1973

Age

47

Relationships
RelSci Relationships are individuals Sierk Pötting likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at BioNTech SE

Relationship likelihood: Strong

Co-Managing Director at JPT Peptide Technologies GmbH

Relationship likelihood: Strong

Co-Founder & Chief Executive Officer at BioNTech SE

Relationship likelihood: Strong

Co-Managing Director at JPT Peptide Technologies GmbH

Relationship likelihood: Strong

Co-Managing Director at AT Impf GmbH

Relationship likelihood: Strong

Co-Founder at MIG Verwaltungs AG

Relationship likelihood: Strong

Chief Strategy Officer & Managing Director at BioNTech SE

Relationship likelihood: Strong

Founder at ATS Beteiligungsverwaltung GmbH

Relationship likelihood: Strong

Founder at H e x a l AG

Relationship likelihood: Strong

Chief Medical Officer at BioNTech SE

Relationship likelihood: Strong

Paths to Sierk Pötting
Potential Connections via
Relationship Science
You
Sierk Pötting
Chief Financial Officer & Chief Operating Officer at BioNTech SE
Education

Ludwig-Maximilians-Universität München is a premier academic and research institutions.

Established in 1885, the University of Arizona, the state's super land-grant university with two medical schools, produces graduates who are real-world ready through its 100% Engagement initiative. Recognized as a global leader, the UA is also a leader in research, bringing more than $606 million in research investment each year, and ranking 20th among all public universities. The UA is advancing the frontiers of interdisciplinary scholarship and entrepreneurial partnerships, and is a member of the Association of American Universities, the 62 leading public and private research universities. It benefits the state with an estimated economic impact of $8.3 billion annually.

Career History
Chief Financial Officer & Chief Operating Officer
2014 - Current

BioNTech SE operates as a clinical-stage biotechnology company. It operates through the following business units: Biotech Business and External Services. The Biotech Business unit consists of Clinical, Technology Platform and Manufacturing segments. It also includes business services operations. The External Services unit consists of External Services segment, which includes activities related to the sale of diagnostic products, peptides, retroviral vectors for clinical supply, development and manufacturing services. The company was founded by Christopher Huber, Ozlem Tureci and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

Consultant
Prior

McKinsey GmbH & Co. KG provides business consulting services. The company was founded on October 18, 2011 and is headquartered in Düsseldorf, Germany.

Chief Financial Officer & Vice President
Prior

Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Sierk Pötting. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Sierk Pötting's profile does not indicate a business or promotional relationship of any kind between RelSci and Sierk Pötting.